Indexing
CÁC SỐ TỪ 2011-2023
Tạp chí Y Dược Học
Abstract
Background: Breast cancer in young women (<45 years) often exhibits aggressive biological behavior and poor prognosis. Among molecular markers, p53 and Ki-67 have been widely investigated for their roles in tumor progression and prognostic implications; Objectives: This study aimed to evaluate the relationship between p53 and Ki-67 expression and clinicopathologic characteristics in young breast cancer patients.
Materials and methods: A cross-sectional descriptive study was conducted on 51 patients under 45 years old diagnosed with invasive breast carcinoma at Hue University of Medicine and Pharmacy Hospital between January 2023 and June 2025. Hematoxylin–eosin and immunohistochemistry (p53, Ki-67, ER, PR, Her2) were performed. Associations between markers and clinicopathologic features were analyzed using the Chi-square test, with statistical significance set at p<0.05.
Results: The mean age was 38.5 years, with the 35–40 age group accounting for 56.9%. The predominant histologic type was invasive carcinoma of no special type (NST, 76.5%). Stage II–III tumors represented nearly 80% of cases, with axillary lymph node metastasis observed in 58.8%. p53 positivity was found in 41.2% of cases, while high Ki-67 expression (≥14%) was detected in 82.5%. p53 positivity tended to be higher in grade III tumors (62.5%) without statistical significance (p=0.057). High Ki-67 expression was significantly associated with histologic grade (p<0.05) but not with tumor size, nodal status, or stage. Importantly, a significant association was observed between p53 and Ki-67 expression: 90.5% of p53-positive tumors also showed high Ki-67 (p<0.05).
Conclusion: High expression of p53 and Ki-67 is common in breast cancer among young women, reflecting enhanced proliferative activity and higher malignancy. The combined evaluation of p53 and Ki-67 may help explain the poor prognosis in this population and support their potential utility in risk stratification and personalized treatment approaches.
| Published | 2026-06-28 | |
| Fulltext |
|
|
| Language |
|
|
| Issue | Vol. 16 No. 3 (2026) | |
| Section | Original Articles | |
| DOI | 10.34071/jmp.2026.3.731 | |
| Keywords | KBreast cancer, young women, p53, Ki-67, histopathology. Ung thư vú, phụ nữ trẻ, p53, Ki-67, giải phẫu bệnh. |
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2026 Hue Journal of Medicine and Pharmacy
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians 2021, 71(3), 209–249.
Anders, C. K., Johnson, R., Litton, J., Phillips, M., & Bleyer, A. Breast cancer before age 40 years. Seminars in Oncology 2009, 36(3), 237–249.
Nguyen, T. H., Nguyen, T. L., Doan, H. Q., & Pham, X. D. Breast cancer characteristics and survival among young Vietnamese women. Asian Pacific Journal of Cancer Prevention 2020, 21(8), 2359–2366.
Assi, H. A., Khoury, K. E., Dbouk, H., Khalil, L. E., Mouhieddine, T. H., & El Saghir, N. S. Epidemiology and prognosis of breast cancer in young women. Journal of Thoracic Disease 2013, 5(Suppl 1), S2–S8.
Do, T. T., Dinh, H. T. T., Pham, T. N., Nguyen, V. T., Tran, T. L., & Ta, V. T. Delay in the diagnosis and treatment of breast cancer in Vietnam. Cancer Medicine 2020, 9(22), 8102–8111.
Phung, T. H., Tran, T. T., Tran, V. L., Pham, T. T., & Nguyen, V. P. Female breast cancer in Vietnam: A comparison with other Asian countries. Asia-Pacific Journal of Clinical Oncology 2024, 20(2), 95–104.
Silwal-Pandit, L., Vollan, H. K. M., & Børresen-Dale, A. L. TP53 in breast cancer: Mutation types and their functional consequences. Human Mutation 2017, 38(2), 157–168.
Kwak, Y., Kim, S. I., Park, S., Park, H. S., & Kim, Y. J. Prognostic significance of p53 expression in young breast cancer patients. Journal of Breast Cancer 2015, 18(3), 252–258.
Darb-Esfahani, S., Denkert, C., Stenzinger, A., Salat, C., Sinn, B. V., Schem, C., ... & Dietel, M. Role of TP53 mutations in breast cancer prognosis and therapy response. Breast Care 2014, 9(1), 15–20.
Dowsett, M., Nielsen, T. O., A’Hern, R., Bartlett, J., Coombes, R. C., Cuzick, J., ... & Hayes, D. F. Assessment of Ki67 in breast cancer: Recommendations from the International Ki67 in Breast Cancer Working Group. Journal of the National Cancer Institute 2011, 103(22), 1656–1664.
Coates, A. S., Winer, E. P., Goldhirsch, A., Gelber, R. D., Gnant, M., Piccart-Gebhart, M., ... & Senn, H. J. Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015. Annals of Oncology 2015, 26(8), 1533–1546.
Chen, Y., Chen, C., Yang, B., Xu, Q., Wu, F., & Liu, F. Correlation of p53, Ki-67 and breast cancer prognosis in Chinese patients. Oncology Letters 2015, 9(3), 1351–1356.
Wang, J., Liu, Y., Tang, H., Wang, B., & Li, J. The prognostic significance of p53 and Ki-67 expression in young women with breast cancer. World Journal of Surgical Oncology 2019, 17, 17.
WHO Classification of Tumours Editorial Board. WHO classification of tumours, 5th edition, volume 2: Breast tumours. Lyon (France): International Agency for Research on Cancer; 2019.
Pham, T., Bui, L., Kim, G., Hoang, D., Tran, T., Hoang, M., & Tran, T. Cancers in Vietnam - Burden and control efforts: A narrative scoping review. Cancer Control 2019, 26(1), 1073274819863802.
Nguyen, D. H., Truong, P. T., & Phung, T. H. Clinicopathologic features of early-onset breast cancer in Vietnamese women. Vietnam Journal of Oncology 2018, 4(3), 45–52.
Levine, A. J. p53: 800 million years of evolution and 40 years of discovery. Nature Reviews Cancer 2020, 20(8), 471–480.
Yerushalmi, R., Woods, R., Ravdin, P. M., Hayes, M. M., & Gelmon, K. A. Ki67 in breast cancer: Prognostic and predictive potential. The Lancet Oncology 2010, 11(2), 174–183.
Inwald, E. C., Klinkhammer-Schalke, M., Hofstädter, F., Zeman, F., Koller, M., Gerstenhauer, M., & Ortmann, O. Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry. Breast Cancer Research and Treatment 2013, 139(2), 539–552.
Nguyễn Thị Ngọc, Phạm Thị Lan, & Trần Văn Hùng. Nghiên cứu biểu hiện Ki-67, p53 và mối liên quan với đặc điểm mô bệnh học trong ung thư vú. Tạp chí Y học Việt Nam 2020, 497(1), 45–52.